Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Artistic representation of the kit of parts or building a do-it-yourself automated cell culturing system. Wong et al. design and build a framework that enables high-throughput experiments in systems biology, microbiology and evolution (p 614). Image credit: Katie M. Flynn and Ahmad (Mo) Khalil
Addressing the commercial failure of the antibiotic market should be a priority for governments seeking to encourage development of new drugs against resistant bugs.
Last year, investors scrambled to invest in newly floated biotechs. This, together with a brisk licensing market and policy tailwinds, helped boost the sector, even as an expected M&A boom was late to materialize.
A landscape analysis of the recombinant factor VIII patent sector using network analysis to map the cooperation network among assignees shows emerging technologies that focus on improved methods for rFVIII production and bioactivity performance.
Non-founder total target cash compensation in 2017 increased 8.3% year-over-year at private life sciences companies and 6.4% at private technology companies.